ConductScience.org, home

Paper26318044

Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2.

Ghilardi C and 7 others. Oncotarget, 2015. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2. Papers, record 26318044. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26318044

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2.
PubMed
Journal
Oncotarget
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.48
iCite
Revised in PubMed
2018-11-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ghilardi CCarmen
2Silini AAntonietta
3Figini SSara
4Anastasia AAlessia
5Lupi MMonica
6Fruscio RRobert
7Giavazzi RRaffaella
8Bani MRMaria Rosa

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell MovementMajor topic
Endothelial CellsMajor topic
GlycoproteinsMajor topic
NeoplasmsMajor topic
TrypsinMajor topic
Blotting, Western
Cells, Cultured
Epidermal Growth Factor
Fibroblast Growth Factor 2
Gene Expression Regulation, Neoplastic
Humans
Proteolysis
RNA Interference
Reverse Transcriptase Polymerase Chain Reaction
Tumor Microenvironment
Vascular Endothelial Growth Factor A

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117023682Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.Arterioscler Thromb Vasc Biol2006https://conductscience.org/library/papers/17023682PubMed
217395884Endothelial cell migration during angiogenesis.Circ Res2007https://conductscience.org/library/papers/17395884PubMed
39445254Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2.Arterioscler Thromb Vasc Biol1998https://conductscience.org/library/papers/9445254PubMed
415313892S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer.Cancer Res2004https://conductscience.org/library/papers/15313892PubMed
517406981Regional distribution of human trypsinogen 4 in human brain at mRNA and protein level.Neurochem Res2007https://conductscience.org/library/papers/17406981PubMed
620035377Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109.Breast Cancer Res Treat2010https://conductscience.org/library/papers/20035377PubMed
717480209Unconventional translation initiation of human trypsinogen 4 at a CUG codon with an N-terminal leucine. A possible means to regulate gene expression.FEBS J2007https://conductscience.org/library/papers/17480209PubMed
88294000Cloning of the cDNA encoding human brain trypsinogen and characterization of its product.Gene1993https://conductscience.org/library/papers/8294000PubMed
923258495PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer.Mol Cancer Res2012https://conductscience.org/library/papers/23258495PubMed
1016029158Human mesotrypsin defies natural trypsin inhibitors: from passive resistance to active destruction.Protein Pept Lett2005https://conductscience.org/library/papers/16029158PubMed
1117851543Emerging roles of proteases in tumour suppression.Nat Rev Cancer2007https://conductscience.org/library/papers/17851543PubMed
1222130514Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor's proangiogenic microenvironment.Cell Mol Life Sci2012https://conductscience.org/library/papers/22130514PubMed
1325593998Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.Oncoscience2014https://conductscience.org/library/papers/25593998PubMed
1416457812Trypsins and their role in carcinoma growth.Exp Cell Res2006https://conductscience.org/library/papers/16457812PubMed
1515723303Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line.Int J Cancer2005https://conductscience.org/library/papers/15723303PubMed
1617138934Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis.Arterioscler Thromb Vasc Biol2007https://conductscience.org/library/papers/17138934PubMed
1712947001Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2.Blood2003https://conductscience.org/library/papers/12947001PubMed
1818000791The role of tissue factor pathway inhibitor-2 in cancer biology.Semin Thromb Hemost2007https://conductscience.org/library/papers/18000791PubMed
1924049668Biochemical and structural insights into mesotrypsin: an unusual human trypsin.Int J Biochem Mol Biol2013https://conductscience.org/library/papers/24049668PubMed
2017372906Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas.Int J Cancer2007https://conductscience.org/library/papers/17372906PubMed

See all 29 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
41163337CpG Methylation-Driven Pleiotropic Spliced Isoforms of PRSS3 Facilitate Gastric Intratumor Heterogeneity and Metastasis.Cancer Sci2026https://conductscience.org/library/papers/41163337PubMed
37250150UHRF1/DNMT1-MZF1 axis-modulated intragenic site-specific CpGI methylation confers divergent expression and opposing functions of PRSS3 isoforms in lung cancer.Acta Pharm Sin B2023https://conductscience.org/library/papers/37250150PubMed
35480112CpG Site-Specific Methylation-Modulated Divergent Expression of PRSS3 Transcript Variants Facilitates Nongenetic Intratumor Heterogeneity in Human Hepatocellular Carcinoma.Front Oncol2022https://conductscience.org/library/papers/35480112PubMed
33207594Curcumin Treatment Identifies Therapeutic Targets within Biomarkers of Liver Colonization by Highly Invasive Mesothelioma Cells-Potential Links with Sarcomas.Cancers (Basel)2020https://conductscience.org/library/papers/33207594PubMed
30829570A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing.Elife2019https://conductscience.org/library/papers/30829570PubMed
30755669PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma.Sci Rep2019https://conductscience.org/library/papers/30755669PubMed
29629340Enterokinase Enhances Influenza A Virus Infection by Activating Trypsinogen in Human Cell Lines.Front Cell Infect Microbiol2018https://conductscience.org/library/papers/29629340PubMed
28844099Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.J Mol Med (Berl)2017https://conductscience.org/library/papers/28844099PubMed
28463992Small molecule inhibitors of mesotrypsin from a structure-based docking screen.PLoS One2017https://conductscience.org/library/papers/28463992PubMed
26957636Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapy.Biochem J2016https://conductscience.org/library/papers/26957636PubMed

Download CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26318044

GET https://conductscience.org/api/papers/v1/26318044/references?page=2